Is the bad news priced in? This hit over $100 in February and had dropped back down and done absolutely nothing since. What will it take? Management seems to think by adding a few pennies to the dividend it will keep investors interested. News flash "it ain't happening!"
....According to Zacks, “Gilead’s first-quarter earnings were above expectations as well as the year-ago figure. Total revenues climbed substantially over the prior year. We are impressed with Harvoni, which was up approximately 70% sequentially in the first quarter. We are pleased with the company’s dividend and share repurchase program, which should increase shareholder return. We are nevertheless concerned about additional pricing measures in the form of rebates and discounts which could lead to a slowdown in Harvoni sales in 2015. The anticipated continued decline in Atripla sales due to newer HIV therapies is also concerning. Meanwhile, several companies including AbbVie Inc. have launched their HCV treatments in the market.”
GILD has been the subject of a number of other recent research reports. Analysts at Vetr downgraded shares of Gilead Sciences from a “buy” rating to a “hold” rating and set a $127.24 price target on the stock in a research note on Wednesday. Analysts at Argus set a $150.00 price target on shares of Gilead Sciences and gave the company a “buy” rating in a research note on Tuesday, June 23rd. Analysts at Sanford C. Bernstein reiterated an “outperform” rating and set a $125.00 price target on shares of Gilead Sciences in a research note on Friday, May 29th. Analysts at Deutsche Bank reiterated a “buy” rating and set a $125.00 price target on shares of Gilead Sciences in a research note on Saturday, May 23rd. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Gilead Sciences in a research note on Saturday, May 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $122.51.
I think the Greece downside has already played out. The vote will more than likely be yes and the europeans will once again restructure their debt. The PM will have to step down and then they'll have another election and a new gov't to deal with. Basically more of the same.
The only certainty in today's market is uncertainty. It's always something sayeth Gilda!
I can't find any bad news anywhere specific to Cisco. Technically however its been a trainwreck. Currently it is right at its 200 dma and flashing oversold. If it doesn't bounce here then I don't know what's going on. Maybe something behind the scenes that just hasn't shown itself to us yet. Weird!
Any idea what is keeping it down? Fidelity has a very bullish rating of "9" under analyst ratings. Doesn't make sense. I know they made an acquisition yesterday in a security company but would think this would be a move in the right direction. I'm totally baffled! Doesn't speak well for the new leadership whatsoever.
It doesn't matter what the outcome of the vote is. They have no money! EU is all that matters. If they are refused further loan, they are out of the euro and their own currency ain't worth dung.
"Ultimately, at less than 11 times forward earnings and with a growing product portfolio, Gilead Sciences' stock appears still to have plenty of room to run higher."
Wow! Maybe they should switch to android! lol